Molecular Diagnostic laboratory at the New York Genome Center has partnered with the iHope Genetic Health (iGH) initiative to offer pro bono genetic testing for undiagnosed children in under-resourced communities in low-to middle-income countries. This collaboration signifies a significant advancement in the expansion of the iGH network, strengthening the program's ability to create a worldwide influence. #GeneticHealth #HealthcareAccess #GlobalImpact #genomesequencing #raredisease
Junaid Shabbeer
2 个月
A wonderful program!
Wael Osman
2 个月
Fantastic update!
Assistant Professor/Attending | Memorial Sloan Kettering Cancer Center | Molecular Oncology
2 个月Very exciting! How are individuals identified to participate? Will international sanctions on certain countries that has already left them with almost no access to genetic testing, impact their ability to take advantage of the program?